Research progress of mesenchymal stem cell exosomes in multiple organ inflammatory diseases

Abstract

Inflammation is generally considered as a pathological process, and the occurrence of multi-organ inflammatory diseases is usually accompanied by an inflammatory response. Persistent inflammation can eventually lead to organ dysfunction. In recent years, the study of mesenchymal stem cell-derived exosomes has found its unique anti-inflammatory effect, which provides a new idea for the treatment of multi-organ inflammatory diseases. This article reviews the effect of mesenchymal stem cell exosomes on multi-organ inflammatory diseases.

Keywords

Inflammation / Exosomes / Mesenchymal stem cells

References

[1] Li M, Zhu W, Zhang H. Research progress of exosomes derived from different mesenchymal stem cells in skin wound repair. Chinese Journal of Injury Repair and Wound Healing. 2021; 16(06): 515-519.

[2] Pan J, Zhou L, Zhang C, et al. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. Signal Transduct Target Ther. 2022; 7(1): 177. PMid:35665742. https://doi.org/10.1038/s41392-022-01038-3

[3] Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol. 2021; 97: 107823. PMid:34102486. https://doi.org/10.1016/j.intimp.2021.107823

[4] Harrell CR, Jovicic N, Djonov V, et al. Mesenchymal Stem Cell- Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019; 8(12): 1605. PMid:31835680. https://doi.org/10.3390/cells8121605

[5] Zhao J, Li Y, JiaR, et al. Mesenchymal Stem Cells-Derived Exosomes as Dexamethasone Delivery Vehicles for Autoimmune Hepatitis Therapy. Front Bioeng Biotechnol. 2021; 9: 650376. PMid:33859980. https://doi.org/10.3389/fbioe.2021.650376

[6] Shen J, Zhang M, Peng M. Progress of exosome research in systemic lupus erythematosus. Cytokine X. 2022; 4(2-3): 100066. PMid:35656386. https://doi.org/10.1016/j.cytox.2022.100066

[7] Cai G, Cai G, Zhou H, et al. Mesenchymal stem cell-derived exo- some miR-542-3p suppresses inflammation and prevents cerebral infarction. Stem Cell Res Ther. 2021; 12(1): 2. PMid:33407827. https://doi.org/10.1186/s13287-020-02030-w

[8] Rodríguez-Gómez JA, Kavanagh E, Engskog-Vlachos P, et al. Mi- croglia: Agents of the CNS Pro-Inflammatory Response. Cells. 2020; 9(7): 1717. PMid:32709045. https://doi.org/10.3390/cells9071717

[9] Chen Y, Li J, Ma B, et al. MSC-derived exosomes promote recovery from traumatic brain injury via microglia/macrophages in rat. Aging. 2020; 12(18): 18274-18296. PMid:32966240. https://doi.org/10.18632/aging.103692

[10] Zhang Z, Zou X, Zhang R, et al. Human umbilical cord mesenchy- mal stem cell-derived exosomal miR-146a-5p reduces microglial- mediated neuroinflammation via suppression of the IRAK1/TRAF 6 signaling pathway after ischemic stroke. Aging (Albany NY). 2021; 13(2): 3060-3079. PMid:33479185. https://doi.org/10.18632/aging.202466

[11] Lai M, Xu E, Qiu M, et al. Role of exosomes in neuroinflamma- tion after cerebral ischemia. International Journal of Cerebrovascular Diseases. 2021; 29(02): 132-137.

[12] Li S, Luo L, He Y, et al. Dental pulp stem cell-derived exo- somes alleviate cerebral ischaemia-reperfusion injury through sup-pressing inflammatory response. Cell Prolif. 2021; 54(8): e13093. PMid:34231932. https://doi.org/10.1111/cpr.13093

[13] Tian T, Cao L, He C, et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021; 11(13): 6507-6521. PMid:33995671. https://doi.org/10.7150/thno.56367

[14] Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, et al. Inflam-mation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018; 186: 73-87. PMid:29330085. https://doi.org/10.1016/j.pharmthera.2018.01.001

[15] Li S, Li L, Guo R, et al. Research progress on the mechanism of exo- somes in improving myocardial ischemia-reperfusion injury. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease. 2021; 19(1).

[16] Xu R, Zhang F, Chai R, et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polar- ization. J Cell Mol Med. 2019; 23(11): 7617-7631. PMid:31557396. https://doi.org/10.1111/jcmm.14635

[17] Xiong YY, Gong ZT, Tang RJ, et al. The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction. Theranostics. 2021; 11(3): 1046-1058. PMid:33391520. https://doi.org/10.7150/thno.53326

[18] Fu X, Huo R, Deng S, et al. Exosomes derived from LPS-stimulated bone marrow mesenchymal stem cell improve myocardial inflammation and fibrosis after myocardial infarction in mice. Chinese Journal of Clinical Pharmacology and Therapeutics. 2019; 24(08): 841-851.

[19] Zhao X, Mao X, Li C, et al. Role of mesenchymal stem cells in the treatment of myocardial ischemia-reperfusion injury. Journal of Clinical Rehabilitative Tissue Engineering Research. 2022; 26(1).

[20] Liao X, Guo G. Research progress of the influence mechanism of ω-3 polyunsaturated fatty acid on acute lung injury in inflammatory response and immune function. Chinese Journal of Injury Repair and Wound Healing. 2020; 15(03): 219-222.

[21] Lanyu Z, Feilong H. Emerging role of extracellular vesicles in lung injury and inflammation. Biomed Pharmacother. 2019; 113: 108748. PMid:30877881. https://doi.org/10.1016/j.biopha.2019.108748

[22] Sun M, Li H, Tan D, et al. Research progress on exosomes in pul-monary inflammatory diseases. Practical Preventive Medicine. 2021; 28(1): 124-128. PMid:34869762. https://doi.org/10.1155/2021/3883204

[23] Xia L, Zhang C, Lv N, et al. AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages. Theranostics. 2022; 12(6): 2928-2947. PMid:35401830. https://doi.org/10.7150/thno.69533

[24] Lian X, Su X, Ye J, et al. Therapeutic effect and underlying mecha- nismof exosomes from human adipose-derived stem cells on smokeinduced inflammation and lung injury in mice. Journal of Third Military Medical University. 2021; 43(20).

[25] Yang YM, Kim SY, Seki E. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. Semin Liver Dis. 2019; 39(1): 26-42. PMid:30809789. https://doi.org/10.1055/s-0038-1676806

[26] Herkel J, Schmidt-Arras D. Mediators of liver inflammation and carcinogenesis. Semin Immunopathol. 2021; 43(4): 477-479. PMid:34528106. https://doi.org/10.1007/s00281-021-00880-x

[27] Tang H, Zhang Y, Chen Y. Application value of stem cell-derived exosomes in the inflammatory drive of acute liver failure. Chinese Hepatology. 2022; 27(1): 8-11.

[28] Shao M, Xu Q, Wu Z, et al. Exosomes derived from human um- bilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res Ther. 2020; 11(1): 37. PMid:31973730. https://doi.org/10.1186/s13287-020-1550-0

[29] AlYousef A, AlSahow A, AlHelal B, et al. Glomerulonephritis Histopathological Pattern Change. BMC Nephrol. 2020; 21(1): 186. PMid:32423387. https://doi.org/10.1186/s12882-020-01836-3

[30] NalewajskaM, Gurazda K, Styczyska-Kowalska E, et al. The Role of MicroRNAs in Selected Forms of Glomerulonephritis. Int J Mol Sci. 2019; 20(20): 5050. PMid:31614644. https://doi.org/10.3390/ijms20205050

[31] Bochon B, Kozubska M, Surygała G, et al. Mesenchymal Stem Cells-Potential Applications in Kidney Diseases. Int J Mol Sci. 2019; 20(10): 2462. PMid:31109047. https://doi.org/10.3390/ijms20102462

[32] Zhang H, Wang L, Li C, et al. Exosome-Induced Regulation in Inflammatory Bowel Disease. Front Immunol. 2019; 10: 1464. PMid:31316512. https://doi.org/10.3389/fimmu.2019.01464

[33] Liu J, Sun W, Song M, et al. Mesenchymal stem cell exosomes al-leviate ulcerative colitis in mice by inhibiting activation of COX-2 and NF-κB and phosphorylation of p38 MAPK. Chinese Journal of Immunology. 2021; 37(14): 1688-1692, 1700.

[34] Ocansey DKW, Zhang L, Wang Y, et al. Exosome-mediated ef- fects and applications in inflammatory bowel disease. Biol Rev Camb Philos Soc. 2020; 95(5): 1287-1307. PMid:32410383. https://doi.org/10.1111/brv.12608

[35] Bu X, Li B, Chen W, et al. Research status of exosomes and patho-genesis of inflammatory bowel disease. Chinese Journal of Gastroen- terology. 2020; 25(12): 749-753.